Published in Respir Med on June 01, 2008
Integrative analysis of DNA methylation and gene expression data identifies EPAS1 as a key regulator of COPD. PLoS Genet (2015) 1.52
Early postural blood pressure response and cause-specific mortality among middle-aged adults. Eur J Epidemiol (2011) 1.51
The Association between Continuity of Care and All-Cause Mortality in Patients with Newly Diagnosed Obstructive Pulmonary Disease: A Population-Based Retrospective Cohort Study, 2005-2012. PLoS One (2015) 1.45
Lung function indices for predicting mortality in COPD. Eur Respir J (2013) 1.23
Orally available selective melanocortin-4 receptor antagonists stimulate food intake and reduce cancer-induced cachexia in mice. PLoS One (2009) 0.92
Rhinosinusitis in COPD: symptoms, mucosal changes, nasal lavage cells and eicosanoids. Int J Chron Obstruct Pulmon Dis (2010) 0.90
Profile of glycopyrronium for once-daily treatment of moderate-to-severe COPD. Int J Chron Obstruct Pulmon Dis (2012) 0.89
Insights into interventions in managing COPD patients: lessons from the TORCH and UPLIFT studies. Int J Chron Obstruct Pulmon Dis (2009) 0.86
Does mild COPD affect prognosis in the elderly? BMC Pulm Med (2010) 0.80
Metabolic phenotype and adipose tissue inflammation in patients with chronic obstructive pulmonary disease. Mediators Inflamm (2010) 0.79
The Pneumonia Severity Index as a Predictor of In-Hospital Mortality in Acute Exacerbation of Chronic Obstructive Pulmonary Disease. PLoS One (2015) 0.77
JMV2894, a novel growth hormone secretagogue, accelerates body mass recovery in an experimental model of cachexia. Endocrine (2016) 0.76
Relationship between sniff nasal inspiratory pressure and BODE index in patients with COPD. Lung (2014) 0.76
Improving communication between the physician and the COPD patient: an evaluation of the utility of the COPD Assessment Test in primary care. Patient Relat Outcome Meas (2014) 0.75
Determination of exacerbation predictors in patients with COPD in physical therapy - a longitudinal study. Braz J Phys Ther (2014) 0.75
The BODECOST Index (BCI): a composite index for assessing the impact of COPD in real life. Multidiscip Respir Med (2016) 0.75
Management of COPD, equal treatment across age, gender, and social situation? A register study. Int J Chron Obstruct Pulmon Dis (2016) 0.75
Low oxygen saturation and mortality in an adult cohort: the Tromsø study. BMC Pulm Med (2015) 0.75
Depression, anxiety and panic disorders in chronic obstructive pulmonary disease patients: correlations with tobacco use, disease severity and quality of life. Tob Induc Dis (2017) 0.75
A combined pulmonary function and emphysema score prognostic index for staging in Chronic Obstructive Pulmonary Disease. PLoS One (2014) 0.75
Muscle hypertrophy in hypoxia with inflammation is controlled by bromodomain and extra-terminal domain proteins. Sci Rep (2017) 0.75
The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med (2004) 18.60
An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med (2013) 4.49
An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med (2012) 3.62
Functional status and quality of life in chronic obstructive pulmonary disease. Am J Med (2006) 1.84
An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2015) 1.63
Development and validation of IMAQ: Integrative Medicine Attitude Questionnaire. BMC Med Educ (2003) 1.28
Measurement of fatigue. determining minimally important clinical differences. J Clin Epidemiol (2002) 1.25
An Official American Thoracic Society/European Respiratory Society Policy Statement: Enhancing Implementation, Use, and Delivery of Pulmonary Rehabilitation. Am J Respir Crit Care Med (2015) 1.00
Critical outcomes in pulmonary rehabilitation: assessment and evaluation of dyspnea and fatigue. J Rehabil Res Dev (2004) 0.97
Descriptors of dyspnea by patients with chronic obstructive pulmonary disease versus congestive heart failure. Heart Lung (2004) 0.97
Prognostic assessment in COPD: health related quality of life and the BODE index. Respir Med (2011) 0.93
Pulmonary rehabilitation: WHAT WE KNOW AND WHAT WE NEED TO KNOW. J Cardiopulm Rehabil Prev (2009) 0.89
Patterns of change in symptom clusters with HIV disease progression. J Pain Symptom Manage (2011) 0.84
Differences in illness representation among pulmonary patients and their providers. J Health Psychol (2005) 0.84
Are self-reports of breathing effort and breathing distress stable and valid measures among persons with asthma, persons with COPD, and healthy persons? Heart Lung (2003) 0.83
The language of breathing among individuals with chronic obstructive pulmonary disease. Heart Lung (2004) 0.82
Validation of Chinese version of the Modified Pulmonary Functional Status and Dyspnea Questionnaire with heart failure patients in Taiwan. Am J Crit Care (2008) 0.82
Test-retest reliability of multidimensional dyspnea profile recall ratings in the emergency department: a prospective, longitudinal study. BMC Emerg Med (2012) 0.81
Prognostic assessment of patients with COPD. Lancet (2009) 0.80
A review of nonsurgical treatment for the symptom of irritability in infants with GERD. J Spec Pediatr Nurs (2011) 0.77
Six-minute walking distance in women with COPD. COPD (2011) 0.77
Chronic Bronchitis Is Associated With Worse Symptoms and Quality of Life Than Chronic Airflow Obstruction. Chest (2015) 0.77
Functional status: have we found the gold standard? Chron Respir Dis (2006) 0.75
Pulmonary processes and mechanical ventilation in the ICU patient. Crit Care Nurs Clin North Am (2012) 0.75